BASF lifted force majeure on vitamin A1000

The recent lifting of the force majeure on Vitamin A 1000 has had minimal market impact, with prices continuing to ease. Overall, the vitamins market remains weak to stable, as strong availability and cautious demand keep pressure on prices. Summer maintenance and partial Q3 contracting have done little to shift the current trend. Vitamin market update week 27

Highlights

Vitamin E 50%: US prices remain stable with a slightly weaker trend, while global prices continue to decline due to adequate supply and conservative buying. Summer plant maintenance has not impacted availability.
Vitamin A 1000: BASF lifted its force majeure, but market impact is minimal. Prices are steadily declining amid strong supply, and no changes are expected in the current weak trend.
Vitamin D3 500: Prices are stable to slightly weaker FOB China, yet still high. Other regions show stability despite tight supply.
D-Calpan: Prices are mostly stable in China and the US, but slightly weaker in Europe due to currency effects. No major changes from previous weeks.
Vitamin B3: Prices continue to decline as Chinese suppliers push volume in a weak market. One manufacturer remains under force majeure.

In partnership with Feed Additive Prices

Vitamin E 50%

Prices in the USA are still relatively stable, with a slight weakening tone to it. In other regions, the price continues to decline step by step as availability seems fine and buyers remain conservative. Several manufacturers are carrying out summer plant maintenance, but that seems to have no impact so far on the supply chain or stocks. A decent portion of Q3 is contracted.

Vitamin A 1000

BASF has lifted the force majeure now also on vitamin A1000. No specific impact on the market has been seen so far. Similar to previous weeks/months, the prices continue to decline step by step as availability seems more than fine. Market participants indicate that no nearby changes are expected in the current weak trend. Only a relatively small portion of Q3 has been contracted.

VITAMIN PRICES: Here the market prices of 3 important vitamins are tracked – check it out…

Vitamin D3 500

No significant changes were seen compared to previous weeks. Prices FOB China are stable to slightly weaker, but still at a relatively high level. Prices in other regions are mostly stable, and availability remains tight. Q3 is mostly contracted.

D-Calpan

Mostly stable prices in China and the USA. But slightly weaker prices in Europe due to the stronger EUR against the USD. Overall, no significant changes are seen compared to previous weeks. Q3 is partly contracted.

Vitamin B3

Several Chinese suppliers continue to be aggressive on price and want to move volume. This has led to further price decline in an already low-priced market. One of the manufacturers is still under force majeure, after an incident at the beginning of this year. The overall market remains weak. Q3 is partly contracted.